Zdrowie i gospodarka · 16/08/2007

FDA Amends Blood and Blood Component Regulations to Align with Industry Practices

The Food and Drug Administration (FDA) is revising its biologics regulations to align with current industry practices and eliminate outdated requirements, aiming to reduce regulatory burdens on the blood industry while maintaining public health protection.